Ionis Closer To First Wholly-Owned Drug Launch With Olezarsen Phase III Success

Drug Targets apoC-III To Lower Triglycerides

 
• By Mandy Jackson
  
Anatomical model of pancreas on doctor table over background gastroenterologist consulting woman patient
A high dose of olezarsen eliminated risk of acute pancreatitis in FCS • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D